维普中文期刊产品整合服务
8篇 您的检索式:作者名="Metalidis C"
    题名 作者 年代 出处 被引量
1Expression of CYP'3A5 and P-glycoprotein in renal allografts with histological signs of calci- neurin inhibitor nephrotoxicity 显示文摘Metalidis C Lerut E Naesens M 2011Transplantation2011,91,10:1
2The P450 oxidoreductase * 28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3AS-expressing renal recipients 显示文摘de Jonge H Metalidis C Naesens M 2011Pharmacogenomics2011,12,9:1
3The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5- expressing renal recipients显示文摘de JONGE H METALIDIS C NAESENS M et cd 2011Pharmacogenomics2011,12,9:1
4The P450 oxi- doreductase * 28 SNP is associated with low initial taerolimus exposure and increased dose requirements in CYP3AS-express- ing renal recipients 显示文摘de Jonge H Metalidis C Naesens M 2011Pharmacogenomics2011,12,:1
5The P4s0 oxidoreductase * 28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients 显示文摘DE JONGE H METALIDIS C NAESENS M 2011Pharmacogenomics2011,12,9:1
6The P450 oxidoreductase 28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3AS-expressing renal recipients 显示文摘de Jonge H Metalidis C Naesens M 2011Pharmacogenomics2011,12,9:1
7Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity显示文摘Metalidis C Lerut E Naesens M 2011Transplantation2011,91,10:1
8The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients 显示文摘de Jonge H Metalidis C Naesens M 2011Pharmacogenomics2011,12,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费